KARD KARD
Company Profile ↓Company Overview
KARD (KARD) is a publicly traded company listed on with a market capitalization of $1.81B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 76.7%, reflecting efficient use of shareholder capital.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -7.95% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | -15.02% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- RSI (14)47.90 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 76.7%.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 26.08M | 58.71M |
| Operating Income | -26.08M | -58.71M |
| EBITDA | -25.33M | -56.59M |
| Interest Expense | - | - |
| Pretax Income | -22.19M | -56.07M |
| Tax Provision | -4.17M | 0 |
| Net Income | -18.02M | -56.07M |
| Diluted EPS | -0.29 | -0.90 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 96.66M | 201.84M |
| Operating Income | -96.66M | -201.84M |
| EBITDA | -96.31M | -195.99M |
| Interest Expense | - | - |
| Pretax Income | -88.66M | -196.45M |
| Tax Provision | 0 | -4.51M |
| Net Income | -88.66M | -191.94M |
| Diluted EPS | -1.42 | -3.20 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Total Assets | 63.53M | 390.94M |
| Current Assets | 50.32M | 345.35M |
| Cash & Equivalents | 49.40M | 108.99M |
| Inventory | - | - |
| Receivables | - | - |
| Total Liabilities | 146.72M | 641.28M |
| Current Liabilities | 8.29M | 37.54M |
| Long Term Debt | - | - |
| Total Debt | 9.54M | 13.83M |
| Total Equity | -83.19M | -250.34M |
| Shares Outstanding | 89.34M | 89.34M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | -18.82M | -151.06M |
| Investing Cash Flow | -36.42M | -237.04M |
| Financing Cash Flow | 105.01M | 447.81M |
| Capital Expenditure | -36.42M | -6.64M |
| Free Cash Flow | -55.24M | -157.70M |
| Net Change in Cash | 49.77M | 59.71M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Gross Margin % | - | - |
| Operating Margin % | - | - |
| Net Margin % | - | - |
| ROE % | 106.6% | 76.7% |
| ROCE % | -175.0% | -57.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for KARD
Kardigan (KARD) Stock Price At $22 Raises Fresh Valuation Questions - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPLTBrV3dsME5MMmN5S1d5Y2FibUl3QXlXcW0xUGFIRE1wcHhBOEhQZE1FSl81YTNnaHhLR0ZrcWpFZ0F2YTlWNHBrNnRabms3QU1GMzBMR09lZGVhTWo0dVg0X3ZoQ3lmVms5ZWdwT2ZQZ2pRbl95OHE5QnRMTXVrYkRjMjRuRWFpZkVxN2…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE1fZnlIdXRsNUEyNzBTM1dQQUVfWTJQUjVFblI3VlFRMGt4QmgxZXljZEJ3TDlFejhxTzZjT2Z0anQyQkhZbzhDMnEyY1l2Q1RJ?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Top Kardigan (KARD) Competitors 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ3dIcjM1aVVSa1BWWTdqX1BreE02bjNCNmxmeERWOF9TdWhBS3dvQkRtbE93Q1dOVmlwR0pMajczSm9oMjVXODhwUms2ci1iOXNyZlowdURrN2tPYXJzODcwZkRxaWlFZHBWZ21rd3VhSnBXenN4S0pFS1haR0dZNQ?oc=5" target="_…
Cardiology biotech Kardigan seeks up to $370M in U.S. IPO - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNd3UxUlZTWmtCUlZTXzNpbERkUDY4WnJ5T1hTYXVKN0JCR1ZzRDVFbEhVdG92QnpadTlINmRUZkhrWG05Zjk4bTJULTJqTWZIb2ZscnJnUmM3U3VGeHpiODBSRlZCRWpnNmhNWkZsemM1WGI2THFpaV9sWWtwU1lOeHRDbTh2NEhmaWhR?o…
Biotech Kardigan Rises Nearly 2% After $400 Million IPO - Bloomberg.com
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPSFpyaEh5clFFS3hJUDVETFJBclVOMFVnQ1loN0hwWVRRd0ZvOFJnUUs2MTlxaUZFc1FFMVFtOG43VF9Wa29pLWRPNzZwdnRLb0JyTHBsUDlCUEFyaDBSd2F2T29QTlJxZk1NVjNGYUpObmdadFJRUExITzlhaVJ5emctMXRPVXNMWU5naE…
KARD Increases Offering Size and Pricing Range - GuruFocus
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQc3pCTzNYa2VHa0hDTFlIMnlQajNBMWozRW9OWGdZUmNyR3ZSdU5uMGJzYWI4ZWhfaTVvMjhBNnByLW5Va2lBVGdodDRNUHptOWdwVHM3U1VjaWxWajZ6RnBLeDI5cFI1X3pXS0NMYk5SSkQzUXpPVGVGUGJwbU81QVdsTEcyWHBPd1JMM0…
KARD — Frequently Asked Questions
What is the current share price of KARD?
As of 2026-08-05 17:25 PDT, KARD trades at $20.25 on NASDAQ/NYSE. Its 52-week range is $19.73 to $25.90.
What is the market capitalisation of KARD?
KARD has a market capitalisation of $1.81B on NASDAQ/NYSE.
What is the P/E ratio of KARD?
KARD trades at a trailing price-to-earnings (P/E) ratio of -6.33. Its price-to-book (P/B) ratio is -7.23.
What is the return on equity (ROE) of KARD?
KARD has a return on equity (ROE) of 76.67%. Its return on capital employed (ROCE) is -57.11%.
Is KARD a good stock to buy?
This page provides a data-driven analysis of KARD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.